Thursday 19 October 2017

Common eye drug may be answer to baldness

John von Radowitz

A sidE effect of a common eye drug could lead to its use as a baldness treatment, say researchers.

Lumigan is administered as eye drops to patients with glaucoma, a condition caused by excess fluid in the eye that leads to vision loss.

But it has one marked side effect -- it can stimulate the growth of eyelashes.

The new research suggests the active ingredient in Lumigan, bimatoprost, has the same effect on the scalp.

Trials are under way to see if bimatoprost can reverse hair loss in men and women.

If successful, it may not be long before the drug is re-marketed as a baldness treatment.

Scientist Professor Valerie Randall, from the University of Bradford, said: "Our findings show bimatoprost does stimulate growth in human scalp hair follicles."

Irish Independent

Editors Choice

Also in World News